0001237899-12-000034.txt : 20120321
0001237899-12-000034.hdr.sgml : 20120321
20120321085140
ACCESSION NUMBER: 0001237899-12-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120315
FILED AS OF DATE: 20120321
DATE AS OF CHANGE: 20120321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12704847
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2012-03-15
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2012-03-15
4
M
0
4600
18.61
A
4600
D
Common Stock
2012-03-15
4
S
0
4600
110.77
D
0
D
Common Stock
2012-03-15
4
M
0
400
18.61
A
400
D
Common Stock
2012-03-15
4
S
0
400
111.06
D
0
D
Common Stock
2012-03-15
4
M
0
5000
18.61
A
5000
D
Common Stock
2012-03-15
4
S
0
5000
115
D
0
D
Non-Qualified Stock Option (right to buy)
18.61
2012-03-15
4
M
0
4600
D
2019-01-02
Common Stock
4600
10400
D
Non-Qualified Stock Option (right to buy)
18.61
2012-03-15
4
M
0
400
D
2019-01-02
Common Stock
400
10000
D
Non-Qualified Stock Option (right to buy)
18.61
2012-03-15
4
M
0
5000
D
2019-01-02
Common Stock
5000
5000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,600 shares of Company stock on March 15, 2012 at prices ranging from $110.01 to $110.99.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 15, 2012 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on March 15, 2012 at prices ranging from $111.00 to $111.10.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 15, 2012 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Joseph L. Goldstein
2012-03-16